Tolerx Employee Directory

Tolerx corporate office is located in 300 Technology Sq Ste 3, Cambridge, Massachusetts, 02139, United States and has 51-200 employees.

Tolerx Global Presence

globalPresence illustration
North America1-10

Key Employees of Tolerx

  • AT
    United States flag for contact location.
    Alem Truheh

    Senior VP, Research & Preclinical Development

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Index of contact profiles from Tolerx

Hundreds of professionals searching for Tolerx have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at Tolerx

Explore people who held key positions, contributed to Tolerx's success, and advanced their careers.

  1. Senior Managing Direct... at Mesirow Financial

    Worked as Member

    at Tolerx

    Flame icon indicating likelihood to engage via phone.email Thomas Galuhn Email direct Thomas Galuhn Direct
  2. Senior Director, Field... at MannKind

    Worked as Medical Science Liaison & Recruitment Speciali...

    at Tolerx (2007-2023)

    email Anthony DeFilippo Email direct Anthony DeFilippo Direct

Explore More

People from Similar Companies in the Manufacturing Industry Located in Massachusetts, United States

Frequently Asked Questions Regarding Tolerx Employees

How many employees does Tolerx have?
Tolerx has 51-200 employees
Who are Tolerx key employees?
Some of Tolerx key employees are Alem Truheh
Where is Tolerx located?
Tolerx’s headquarters are located at 300 Technology Sq Ste 3, Cambridge, Massachusetts, 02139, United States
How do I contact Tolerx?
Tolerx Contact Info: Phone number: (617) 354-8100 Website: www.tolerx.com
What does Tolerx do?

Tolerx, Inc., a world leader in the understanding of T cell function, is developing novel therapies intended to treat autoimmune diseases, diabetes, and cancer by specifically modulating T cell activity. company's pipeline includes its lead candidate, otelixizumab, a targeted T cell immunomodulator in Phase 3 development for the treatment of type 1... diabetes that is partnered with GlaxoSmithKline. TRX1, a Phase 1 candidate, is a nonlytic anti-CD4 antibody that is being developed for the treatment of aberrant or untoward immune responses. Tolerx also has three preclinical candidates, TRX518, TRX585, and TRX385, which enhance immune responses and as such are being evaluated for potential benefit in the treatment of cancer and chronic infections. Tolerx is a privately held company headquartered in Cambridge, MA USA.Read More

Is Tolerx a public company?
Tolerx is private company therefore does not currently have an official ticker symbol
See more information about Tolerx Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.